"It's exciting to see these new results from the cardiometabolic post hoc analysis, which showed that while benefits were most pronounced in people who achieved greater than 15% weight loss, clear improvements in glycemic parameters and CV risk factors were observed in patients taking oral semaglutide 25 mg, regardless of how much weight was lost, based on the groups observed." Additional OASIS 4 data Indirect comparison between formulations Data presented from an indirect treatment comparison of the OASIS 4 (oral semaglutide) and STEP 1 (injectable semaglutide) phase 3 clinical trials in adults with obesity and overweight demonstrated that key outcomes like the share of people reaching 5%, 10%, 15%, 20% body weight reductions, positive changes in cardiometabolic markers, and quality of life scores were comparable for the oral and injectable formulations in these trials, respectively
These include urinating when the urge arises rather than delaying, ensuring complete bladder emptying, and urinating shortly after sexual intercourse to flush bacteria from the urethra
You do not need your Medicare card to begin
Your healthcare team will monitor thyroid labs at appropriate intervals to ensure your levothyroxine dose remains correct as weight decreases
For the reverse calculation, when you know the mg you want and need to find the units, flip the formula: Units = (Desired mg / Concentration) x 100
Keep the semaglutide pen or vial upright to prevent leakage
